shot-button
Subscription Subscription
Home > Sports News > Cricket News > Article > PCB bans domestic pacer for failing dope test

PCB bans domestic pacer for failing dope test

Updated on: 15 October,2014 07:55 AM IST  | 
PTI |

A domestic Pakistani pacer Umaid Asif has been banned for one-year after failing an anti-doping test by the country's cricket board

PCB bans domestic pacer for failing dope test

Karachi: A domestic Pakistani pacer Umaid Asif has been banned for one-year after failing an anti-doping test by the country's cricket board (PCB).


Umaid, who plays for Sialkot region and KRL department in domestic cricket and is a leading bowler, tested positive after random in-competition tests during the departments T20 Cup held in Lahore in November 2013.


"He has been banned by the PCB's Anti-Doping Tribunal for violating the Board's Anti-Doping Code," the PCB said in a statement.


Umaid, 30, who has taken 106 wickets in 35 first class matches, was representing KRL against the State Bank of Pakistan when he was called for the random test.

The PCB said it had sent the urine samples to the National Dope Testing Laboratory (WADA-accredited laboratory) in New Delhi for analysis which vide its analytical report dated 10-01-2014 gave an adverse analytical finding for substances "prednisolone and prednisone", both of which fall under category S9 Glucocorticosteroids in the 2013 WADA prohibited list .

The PCB said Umaid had been given a fair chance to plead his case before the anti-doping tribunal but he failed to satisfy them.

Umaid will serve the ban from January, 2014. The PCB recently said it would come down hard on bowlers with suspect bowling actions and those who violate anti-doping rules in domestic cricket.

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!


Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK